Diffusion Pharmaceuticals, Inc. reported raising $15.8M in a private placement filing on March 16, 2017
Mar 18, 2017
Diffusion Pharmaceuticals, Inc. is a clinical stage company, which engages in the development of treatment for life threatening conditions. It offers Trans Sodium Crocetinate. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.
In The News
Brain Tumor Market is Projected to Propel Humbly at a CAGR of 4.19% in the 7MM for the Study Period 2017-30, Says DelveInsight; Out of all targeted Brain Tumor pipeline therapies, VAL-083 and Durvalumab target unmethylated MGMT form of glioblastoma while
Mar 10, 2021 - PR Newswire
Jan 18, 2021 - DirectorsTalk Interviews
Jan 16, 2021 - DirectorsTalk Interviews